Related Experiment Video
Updated: Nov 22, 2025

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
Published on: March 24, 2015
BIO bragg gratings on microfibers for label-free biosensing
Augusto Juste-Dolz1, Martina Delgado-Pinar2, Miquel Avella-Oliver3
1Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, 46022, Valencia, Spain.
Bio Bragg Gratings (BBGs) offer a novel biosensing approach by patterning protein bioreceptors on optical waveguides. This technology enables sensitive, label-free detection of biorecognition events, with tunable optical responses for multiplexed assays.
Area of Science:
- Nanoscience and Nanotechnology
- Bioanalytical Chemistry
- Optical Biosensing
Background:
- Nanoscale phenomena offer new avenues for bioanalytical applications.
- Existing biosensing methods face challenges with non-specific binding and signal interference.
Purpose of the Study:
- To introduce and characterize Bio Bragg Gratings (BBGs) as a novel biosensing platform.
- To explore the design, fabrication, and optimization of BBGs for biorecognition detection.
- To assess the potential of BBGs for label-free, multiplexed bioassays.
Main Methods:
- Fabrication of functional biomolecular gratings using microcontact printing on tapered optical microfibers.
- Characterization of structural features and optical properties of BBGs.
- Experimental demonstration of the transduction principle in a representative immunoassay using protein probes and IgG targets.
- Investigation of non-specific binding in human serum samples.
Main Results:
- Successful fabrication and characterization of BBGs.
- Experimental validation of the transduction mechanism, converting biorecognition events into detectable spectral intensity changes.
- Demonstration of label-free immunoassay capabilities with reduced non-specific binding.
- Evidence of tunable optical responses for potential multiplexing.
Conclusions:
- BBGs represent a promising novel biosensing platform with potential for sensitive, label-free detection.
- The system offers advantages in minimizing non-specific binding, particularly in complex biological samples like serum.
- Tunable optical properties pave the way for developing multiplexed devices capable of simultaneous, multiple bioassays.

